2022
|
Invention
|
Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines.... |
2021
|
Invention
|
E-coli. 197 protein. |
|
Invention
|
Production of soluble recombinant protein.
The invention is directed to methods and compositions... |
|
Invention
|
Production of soluble recombinant protein. The invention is directed to methods and compositions ... |
2020
|
Invention
|
Production of soluble recombinant protein without n-terminal methionine. 197 protein. |
2018
|
Invention
|
Expression and purification of crm proteins and related proteins, and protein domains. 197 protein. |
2017
|
G/S
|
Chemicals used in industry and science; chemicals used in industry and science, namely, a folded,... |
2015
|
G/S
|
Treatment of materials by chemical processes; purifying proteins; custom production of bioconjuga... |
|
Invention
|
Expression and purification of crm197 and related proteins. 197 protein. |
|
Invention
|
Expression and purification of crm197 and related proteins. The present invention is directed to ... |
2014
|
Invention
|
Method for producing protein-carbohydrate vaccines reduced in free carbohydrate.
This invention ... |
2013
|
Invention
|
Differential functionalization of polymers with aminooxy reagents. This invention relates to a me... |
|
Invention
|
Differential functionalization of polymers with amino-oxy reagents for diagnostic assays.
This i... |
2010
|
Invention
|
Simple method for simultaneous removal of multiple impurities from culture supernatants to ultral... |
|
Invention
|
Method for enhancing the sensitivity of antibody based assays. There is a constant need for incre... |
|
Invention
|
Method of producing protein-carbohydrate vaccines reduced in free carbohydrate. This invention is... |
|
Invention
|
Method for producing protein-carbohydrate vaccines reduced in free carbohydrate. This invention i... |
2005
|
Invention
|
Use of amino-oxy functional groups in the preparation of vaccines. The invention relates to a pro... |
|
Invention
|
Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccine... |